Table S5 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy

Authors:

MDMatheus Henrique Dias
Matheus Henrique Dias
AFAnoek Friskes
Anoek Friskes
SWSiying Wang
Siying Wang
JNJoao M. Fernandes Neto
Joao M. Fernandes Neto
FGFrank van Gemert
Frank van Gemert
SMSoufiane Mourragui
Soufiane Mourragui
CPChrysa Papagianni
Chrysa Papagianni
HKHendrik J. Kuiken
Hendrik J. Kuiken
SMSara Mainardi
Sara Mainardi
DADaniel Alvarez-Villanueva
Daniel Alvarez-Villanueva
CLCor Lieftink
Cor Lieftink
BMBen Morris
Ben Morris

Open Access

Publisher website

Google Scholar

17 June 2026

other
Published by American Association for Cancer Research (AACR)

DOI:10.1158/2159-8290.32697696

Abstract

Supplementary table 5: Stress-focused drug screens AUC differences in HT-29 cells Area Under the Curve (AUC) from each compound of the stress-focused drug screen in the presence or absence of LB-100. Compounds are ranked by the difference in the AUC between LB-100-treated and untreated samples.

Keywords

STRESS-FOCUSED DRUG
PARADOXICAL ACTIVATION
ONCOGENIC SIGNALING
CANCER TREATMENT
TREATMENT STRATEGY
STRATEGY SUPPLEMENTARY
SUPPLEMENTARY TABLE
CELLS AREA
DRUG SCREENS
DRUG SCREEN